This is the VOA Special English Development Report.

Millions of babies and children could soon be protected against the deadly disease pneumonia. Two leading drug companies have agreed to supply vaccines against pneumococcal disease to the world's poorest countries at a reduced price. Pfizer and GlaxoSmithKline signed the historic Advance Market Commitment agreement last week. The Global Alliance for Vaccines and Immunizations, or GAVI, helpednegotiate the deal. The group says the low cost vaccines could save as many as seven million lives by the year twenty thirty.